HRP20120106T1 - Farmaceutski pripravci entakapona koji su mikronizirani zajedno sa šećernim alkoholima - Google Patents

Farmaceutski pripravci entakapona koji su mikronizirani zajedno sa šećernim alkoholima Download PDF

Info

Publication number
HRP20120106T1
HRP20120106T1 HR20120106T HRP20120106T HRP20120106T1 HR P20120106 T1 HRP20120106 T1 HR P20120106T1 HR 20120106 T HR20120106 T HR 20120106T HR P20120106 T HRP20120106 T HR P20120106T HR P20120106 T1 HRP20120106 T1 HR P20120106T1
Authority
HR
Croatia
Prior art keywords
capsule
entacapone
mill
sugar alcohols
following
Prior art date
Application number
HR20120106T
Other languages
English (en)
Croatian (hr)
Inventor
Kapoor Ritesh
Mate Sanjay
Talwar Munish
Kumar Jain Girish
Original Assignee
Wockhardt Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Limited filed Critical Wockhardt Limited
Publication of HRP20120106T1 publication Critical patent/HRP20120106T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20120106T 2008-02-06 2009-02-06 Farmaceutski pripravci entakapona koji su mikronizirani zajedno sa šećernim alkoholima HRP20120106T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN264MU2008 2008-02-06
PCT/IB2009/050490 WO2009098663A1 (fr) 2008-02-06 2009-02-06 Compositions pharmaceutiques d'entacapone co-micronisée avec des alcools de sucre

Publications (1)

Publication Number Publication Date
HRP20120106T1 true HRP20120106T1 (hr) 2012-02-29

Family

ID=40626966

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20120106T HRP20120106T1 (hr) 2008-02-06 2009-02-06 Farmaceutski pripravci entakapona koji su mikronizirani zajedno sa šećernim alkoholima

Country Status (20)

Country Link
US (1) US8728517B2 (fr)
EP (1) EP2293791B1 (fr)
JP (1) JP5651478B2 (fr)
KR (1) KR101532810B1 (fr)
CN (1) CN101939002B (fr)
AT (1) ATE534382T1 (fr)
AU (1) AU2009211030B2 (fr)
BR (1) BRPI0907727A2 (fr)
CA (1) CA2714113C (fr)
CY (1) CY1116484T1 (fr)
DK (1) DK2293791T3 (fr)
ES (1) ES2377597T3 (fr)
HR (1) HRP20120106T1 (fr)
MX (1) MX2010008707A (fr)
NZ (1) NZ587169A (fr)
PL (1) PL2293791T3 (fr)
PT (1) PT2293791E (fr)
RU (1) RU2010136934A (fr)
SI (1) SI2293791T1 (fr)
WO (1) WO2009098663A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010023828A1 (de) * 2010-06-15 2011-12-15 IIP - Institut für industrielle Pharmazie, Forschungs- und Entwicklungsgesellschaft mbH Pharmazeutisches Präparat, welches Entacapon, Levodopa und Carbidopa enthält
CN106880607A (zh) * 2015-12-15 2017-06-23 北大方正集团有限公司 一种含有瑞戈非尼的口腔崩解片及其制备方法
CN115715767B (zh) * 2022-11-02 2023-06-09 石家庄四药有限公司 一种恩他卡朋片剂的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2642486B2 (ja) * 1989-08-04 1997-08-20 田辺製薬株式会社 難溶性薬物の超微粒子化法
US6599530B2 (en) 1998-09-14 2003-07-29 Orion Corporation Oral compacted composition comprising catechol derivatives
FI109453B (fi) * 1999-06-30 2002-08-15 Orion Yhtymae Oyj Farmaseuttinen koostumus
ATE444746T1 (de) * 2005-06-08 2009-10-15 Orion Corp Eine herstellungsmethode von entacapon- enthaltenden granulaten für orale dosierformen
GB2429645A (en) * 2006-03-10 2007-03-07 Sekhsaria Chemicals Ltd Solid pharmaceutical composition comprising a COMT inhibitor, a starch and a wetting agent

Also Published As

Publication number Publication date
MX2010008707A (es) 2011-03-25
RU2010136934A (ru) 2012-03-20
SI2293791T1 (sl) 2012-03-30
ES2377597T3 (es) 2012-03-29
JP2011526241A (ja) 2011-10-06
NZ587169A (en) 2011-03-31
EP2293791A1 (fr) 2011-03-16
WO2009098663A1 (fr) 2009-08-13
KR20100117096A (ko) 2010-11-02
PL2293791T3 (pl) 2012-04-30
PT2293791E (pt) 2012-01-11
ATE534382T1 (de) 2011-12-15
CN101939002B (zh) 2012-12-26
BRPI0907727A2 (pt) 2017-06-13
CA2714113A1 (fr) 2009-08-13
EP2293791B1 (fr) 2011-11-23
CN101939002A (zh) 2011-01-05
JP5651478B2 (ja) 2015-01-14
CY1116484T1 (el) 2017-03-15
US8728517B2 (en) 2014-05-20
DK2293791T3 (da) 2012-02-13
KR101532810B1 (ko) 2015-06-30
AU2009211030A1 (en) 2009-08-13
US20110052681A1 (en) 2011-03-03
AU2009211030B2 (en) 2013-12-05
CA2714113C (fr) 2015-11-24

Similar Documents

Publication Publication Date Title
ES2699806T3 (es) Composiciones farmacéuticas, disuasivas del abuso, de liberación inmediata
US20100151034A1 (en) Granular pharmaceutical composition of atorvastatin for oral administration
CN101896167B (zh) 药物组合物
JP2015166379A5 (fr)
JP6081436B2 (ja) ヒドロキシアルキルセルロース微粒子
RU2010136935A (ru) Фармацевтические композиции энтакапона, леводопы и карбидопы с улучшенной биодоступностью
EP2647648B1 (fr) Forme galénique solide contenant de l'HYDROXYALKYLCELLULOSE a faible viscosité
CN102631347A (zh) 一种吉非替尼药物组合物及其制备方法
JPWO2013122134A1 (ja) 経口投与用医薬組成物
JP2009502807A5 (fr)
JP5367735B2 (ja) 錠剤の製造方法
CA3207801A1 (fr) Suspension huileuse d'une isotretinoine microparticulaire ayant une biodisponibilite amelioree
JP5974469B2 (ja) 錠剤の製造方法
CN102083410A (zh) 用于制备迅速崩解的片剂的药物制剂
RU2012131951A (ru) Фармацевтическая композиция, содержащая частицы реина или диацереина и способ ее получения
RU2010136934A (ru) Фармацевтические композиции энтакапона, микронизированного с сахарными спиртами
CN102626410A (zh) 一种含有罗氟司特的药物组合物
US11191729B2 (en) Granular material for orally fast disintegrating tablets
CN104000821B (zh) 含有替米沙坦和苯磺酸氨氯地平的口服双层片剂及其制备方法
CN111743902A (zh) 一种包含微粉化形式的口服固体药物组合物及其制备方法
CN104027316B (zh) 一种格列美脲片剂及其制备方法
CN105435144A (zh) 一种生姜微丸及其制备方法
WO2013062073A1 (fr) Comprimé délitable par voie orale contenant une faible dose de ramosétron
JPWO2014157603A1 (ja) 経口投与用医薬組成物
WO2006101462A3 (fr) Preparation pharmaceutique contenant de la perindopril erbumine et procede de preparation et de stabilisation associe